Partners Precision Medicine Biobank Enrolls Over 100K Participants

Partners Precision Medicine Biobank Enrolls Over 100K Participants

Publication date: Jul 11, 2019

July 10, 2019 – Partners HealthCare recently announced that its precision medicine biobank has enrolled over 100,000 individuals, helping researchers and clinicians at Brigham and Women’s Hospital, Massachusetts General Hospital, and other Partners institutions examine how a wide range of factors impact health and disease.

-In addition to the sample size, a key differentiator for our Biobank is the electronic portal that we developed to help researchers search for disease phenotypes and request the data samples that they need for their studies,” said Elizabeth Karlson, MD, Division of Rheumatology, Immunology, and Allergy at Brigham and Women’s Hospital, and one of the original leaders of the Biobank.

-The Biobank combines genotype data, electronic health record data with lifestyle information from a health survey so our researchers can easily search for and request the specifications that they are interested in looking at without the need to recruit the hundreds or thousands of patients often required to carry out a study. “

To date, the Biobank has provided samples or data to over 200 research studies, including current studies focused on genetic impact medications, the role of genetics in rheumatoid arthritis, and risk score associations between sleep duration and disease.

Greater participation in the Biobank enables us to increase the scale and scope of our research and provides our researchers with access to data and information that would otherwise take them years to source,” said Scott T. Weiss, MD, Principal Investigator at the Partners Biobank and Scientific Director of Partners HealthCare Personalized Medicine.

Concepts Keywords
Biobank Biological databases
Biobanks Diseases
Blood Electronic portal
DNA Biobanks
EHR Branches of biology
Genetic Academic disciplines
Genotype Articles
Genotyping Biological specimen
Immunology Research ethics
Integral Biobank ethics
Mass General BioBank Central
Massachusetts General Hospital Genotyping
Partners HealthCare Genotype
PhD
Phenotypes
Rheumatoid Arthritis
Rheumatology
Sleep
Survey

Semantics

Type Source Name
gene UNIPROT IMPACT
drug DRUGBANK Tropicamide
disease MESH Allergy
disease DOID Allergy
disease MESH lifestyle
disease MESH rheumatoid arthritis
disease DOID rheumatoid arthritis
pathway BSID Rheumatoid arthritis
drug DRUGBANK Etoperidone
gene UNIPROT PDC
gene UNIPROT FBN1
disease MESH Cancer
disease DOID Cancer
disease MESH disease progression
disease MESH community
gene UNIPROT OXCT2
gene UNIPROT LARGE1

Similar

Leave a Comment

Your email address will not be published. Required fields are marked *